May 15, 2020 / 11:16 AM / 20 days ago

BRIEF-BAT Says Its Potential COVID-19 Vaccine Shown To Produce Positive Immune Response

May 15 (Reuters) - British American Tobacco PLC:

* BAT - UPDATES ON ITS BIOTECH UNIT KENTUCKY BIOPROCESSING DEVELOPING POTENTIAL VACCINE FOR COVID-19

* BAT - POTENTIAL VACCINE HAS BEEN SHOWN TO PRODUCE A POSITIVE IMMUNE RESPONSE

* BAT - VACCINE CANDIDATE NOW POISED TO PROGRESS TO NEXT STAGE WHICH WILL BE PHASE 1 HUMAN CLINICAL TRIALS PENDING FDA AUTHORISATION

* BAT - CLINICAL TRIAL COULD START AS EARLY AS LATE JUNE, PENDING RESPONSES FROM RELEVANT HEALTH BODIES

* BAT - INVESTED IN ADDITIONAL EQUIPMENT TO BOOST MANUFACTURING CAPABILITIES SHOULD THEY BE NEEDED

* BAT - SUBMITTED PRE-INVESTIGATIVE NEW DRUG PACKAGE TO U.S. FDA WHO HAVE ACKNOWLEDGED SUBMISSION

* BAT - CORRESPONDENCE WITH GOVERNMENT AGENCIES AROUND WORLD CONTINUES Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below